Armistice Capital’s Vaxart VXRT Stock Holding History

Armistice Capital’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-145,523	Closed	-$831K	–	133
2020 Q4	$831K	Hold	145,523	–	–	0.03%	102
2020 Q3	$968K	Hold	145,523	–	–	0.04%	93
2020 Q2	$1.29M	Sell	145,523 -25,054,477	-99%	-$72M	0.06%	74
2020 Q1	$44.6M	Hold	25,200,000	–	–	2.76%	7
2019 Q4	$8.83M	Buy	25,200,000 +1,200,000	+5%	+$397K	0.51%	52
2019 Q3	$8.62M	Buy	+24,000,000	New	+$15.7M	0.57%	44
2018 Q4	–	Sell	-150,000	Closed	-$428K	–	98
2018 Q3	$428K	Buy	150,000 +72,401	+93%	+$220K	0.03%	73
2018 Q2	$235K	Buy	+77,599	New	+$358K	0.02%	71
2017 Q4	–	Sell	-125,315	Closed	-$944K	–	80
2017 Q3	$944K	Buy	125,315 +23,240	+23%	+$158K	0.11%	62
2017 Q2	$752K	Buy	+102,075	New	+$610K	0.1%	59

Other funds holding VXRT

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Armistice Capital's VXRT Position: Q1 2021 in Review

Armistice Capital sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 145,523 shares — an estimated $831K sold.

Armistice Capital first reported a position in VXRT in Q2 2017 and held it in 10 quarters. The position peaked at $44.6M in Q1 2020. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

Armistice Capital reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
Armistice Capital sold 145,523 Vaxart shares in Q1 2021, an estimated $831K.
Armistice Capital first reported a position in Vaxart in Q2 2017 and held it in 10 quarters.
Armistice Capital's Vaxart position peaked at $44.6M in Q1 2020.
159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.